Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin-Reference-Cited by-同舟云学术

Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin

Published:2019-04-26 Issue:10 Volume:62 Page:4949-4966
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Li Yunqi¹^ORCID,He Yuan¹²^ORCID,Shao Ting¹^ORCID,Pei Haixiang¹^ORCID,Guo Weikai¹^ORCID,Mi Dazhao¹^ORCID,Krimm Isabelle³^ORCID,Zhang Yuanjin¹^ORCID,Wang Peili¹^ORCID,Wang Xin¹^ORCID,Liu Mingyao¹²^ORCID,Yi Zhengfang¹²^ORCID,Chen Yihua¹²^ORCID

Affiliation:

1. Shanghai Key Laboratory of Regulatory Biology, The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China

2. Joint Center for Translational Medicine, Fengxian District Central Hospital, 6600th Nanfeng Road, Fengxian District, Shanghai 201499, China

3. Université de Lyon, CNRS, Université Claude-Bernard Lyon 1, ENS de Lyon, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, Villeurbanne 69100, France

Funder

Ministry of Science and Technology of the People's Republic of China

Shanghai Municipal Education Commission

China Scholarship Council

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00059

Reference30 articles.